Crinetics Pharmaceuticals · 5 hours ago
Executive Director, Corporate Legal Counsel
San Diego, CA
Full-time
Onsite
Director/Executive
$264K/yr - $330K/yr
13+ years expCrinetics Pharmaceuticals is a pharmaceutical company based in San Diego, California, developing therapies for endocrine diseases. The Executive Director, Corporate Legal & Governance Counsel will serve as a senior legal leader responsible for advising on global corporate governance, securities law compliance, and strategic transactions.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Serve as a primary legal advisor to the CFO, Head of Investor Relations, and Finance team on corporate transactions, disclosures and public-company obligations
Draft, review and counsel on the company’s SEC filings (Forms 10-K, 10-Q, 8-K, Proxy Statement), and other periodic/occasional disclosures under U.S. securities laws and applicable stock-exchange rules
Oversee and advise on the company’s insider-trading compliance program, Section 16 reporting, 10b5-1 plans, trading windows, blackout periods and pre-clearance frameworks
Manage the company’s public-company corporate governance framework: prepare materials for the Board of Directors and its committees (e.g., audit, compensation, nominating and governance), annual meeting process, minutes, resolutions, charter review, governance records and help ensure best practices
Collaborate closely with the Finance team and outside counsel on financing, capital markets, debt/equity issuances, share repurchases and other strategic corporate transactions
Take ownership of disclosure controls and procedures, internal controls over financial reporting and other processes—regularly evaluate, refine and enhance these processes
Monitor and assess developments in U.S. federal and state securities laws, stock-exchange listing standards, corporate governance trends, proxy advisory-firm developments and global disclosure/regulatory regimes — interpret their impact for the business and recommend appropriate responses
Develop and maintain strong cross-functional relationships with internal stakeholders (finance, controllership, tax, internal audit, treasury, investor relations, communications, R&D, commercial) and external stakeholders (independent auditors, banks, proxy advisors, outside counsel) to align legal, disclosure and governance strategies
Set priorities, manage performance and budget for the oversight of outside counsel
Provide substantive legal support for other corporate-law matters (including subsidiary governance, inter-company agreements, global stock plans, executive compensation) and assist the Chief Legal Officer and broader Legal team as needed
Champion the company’s compliance culture: translate legal/regulatory requirements into pragmatic business guidance, deliver training, drive awareness of governance and disclosure obligations, and foster ethical decision-making across the enterprise
Support the company’s international expansion and global commercialization initiatives, providing legal guidance on the formation, governance, and maintenance of foreign subsidiaries, cross-border transactions, and compliance with international corporate, securities, and anti-corruption laws
Partner with Finance teams to structure and document intercompany arrangements (e.g., cost-sharing, services, IP licensing, and transfer-pricing agreements) consistent with global tax strategy, corporate policies, and regulatory requirements
Advise on cross-border cash management, capital contributions, and financing arrangements, ensuring alignment with global tax efficiency, local regulatory restrictions, and disclosure obligations
Coordinate with regional legal and external advisors to address country-specific legal, governance, and compliance requirements as the company expands into new markets, launches commercial entities, or transitions from clinical to commercial operations internationally
Oversee or support legal due diligence and integration activities for international corporate restructurings, affiliate transactions, and global operational readiness in collaboration with R&D, Commercial, and Supply Chain functions
Other duties as assigned
Qualification
Required
Juris Doctor degree from an accredited law school and minimum of 13 years of post-law school experience in the biotech/pharma sector
Leadership: a minimum of 12 years of experience as a supervisor with strong leadership skills and experience managing and developing high-performing teams
Ability to influence senior executives and cross-functional teams
Strong business acumen and understanding of pharmaceutical business
Demonstrated ability to align global legal and compliance strategies with broader business goals
In addition to top-notch legal skills and a strong ethical center, excellent interpersonal, strategic thinking, communication and organizational skills
Excellent verbal and written communication skills, with the ability to convey complex legal concepts to non-legal stakeholders
Proven track record of successfully managing outside counsel, handling multiple priorities simultaneously, and delivering results under tight deadlines
Highly proficient in Microsoft Office Suite, SharePoint, Microsoft Teams and other programs, particularly Excel and PowerPoint
Preferred
A combination of law firm, in-house (pharma/biotech) experience strongly preferred
Significant corporate securities law, international expansion, and public company experience serving as in-house counsel for a pharmaceutical or biotechnology company
Benefits
Discretionary annual target bonus
Stock options
ESPP
401k match
Top-notch health insurance plans for employees (and their families) to include medical, dental, vision and basic life insurance
20 days of PTO
10 paid holidays
Winter company shutdown
Company
Crinetics Pharmaceuticals
Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2BKey Investors
Frazier Healthcare PartnersNational Institutes of HealthPerceptive Advisors
2026-01-06Post Ipo Equity· $349.22M
2024-10-08Post Ipo Equity· $500M
2024-02-28Post Ipo Equity· $350M
Leadership Team
R. Scott Struthers
Founder, CEO
A
Alan S. Krasner
Chief Endocrinologist
Recent News
BioWorld Financial Watch
2026-01-15
2026-01-07
Company data provided by crunchbase